 Herpesvirus 3, Human
"Herpesvirus 3, Human" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of VARICELLOVIRUS causing CHICKENPOX (varicella) and HERPES ZOSTER (shingles) in humans.
| Descriptor ID |
D014645
|
| MeSH Number(s) |
B04.280.382.100.900.460
|
| Concept/Terms |
Herpesvirus 3, Human- Herpesvirus 3, Human
- Human Herpesvirus 3
- Chickenpox Virus
- Chickenpox Viruses
- Herpes zoster Virus
- Herpes zoster Viruses
- HHV-3
- Varicella-Zoster Virus
- Varicella Zoster Virus
- Varicella-Zoster Viruses
- Herpesvirus 3 (alpha), Human
- VZ Virus
- VZ Viruses
- Herpesvirus Varicellae
- Varicellae, Herpesvirus
- Ocular Herpes zoster Virus
|
Below are MeSH descriptors whose meaning is more general than "Herpesvirus 3, Human".
Below are MeSH descriptors whose meaning is more specific than "Herpesvirus 3, Human".
This graph shows the total number of publications written about "Herpesvirus 3, Human" by people in this website by year, and whether "Herpesvirus 3, Human" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 | | 1996 | 2 | 0 | 2 | | 1997 | 1 | 0 | 1 | | 1998 | 4 | 1 | 5 | | 1999 | 1 | 0 | 1 | | 2002 | 1 | 0 | 1 | | 2003 | 5 | 0 | 5 | | 2004 | 1 | 0 | 1 | | 2005 | 3 | 0 | 3 | | 2006 | 1 | 0 | 1 | | 2007 | 4 | 4 | 8 | | 2008 | 5 | 3 | 8 | | 2009 | 9 | 0 | 9 | | 2010 | 7 | 1 | 8 | | 2011 | 14 | 2 | 16 | | 2012 | 9 | 0 | 9 | | 2013 | 10 | 2 | 12 | | 2014 | 10 | 1 | 11 | | 2015 | 12 | 1 | 13 | | 2016 | 10 | 1 | 11 | | 2017 | 3 | 1 | 4 | | 2018 | 6 | 1 | 7 | | 2019 | 9 | 1 | 10 | | 2020 | 4 | 3 | 7 | | 2021 | 4 | 1 | 5 | | 2022 | 0 | 3 | 3 | | 2023 | 0 | 5 | 5 | | 2024 | 2 | 4 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Herpesvirus 3, Human" by people in Profiles.
-
Arumugam I, Rajasekaran SS, Gopalakrishnan K, Gnanaskandan S, Jeganathan SN, Athi J, Shanmugaraj R, Ramesh R, Shankar V, Krishnasamy K, Ranganathan LN, Balakrishnan U, Mahalingam R, Bubak AN, Nagel MA, Srikanth P. Diagnostic value of anti-VZV IgG in neurological diseases among varicella unvaccinated individuals. J Neurovirol. 2024 06; 30(3):327-335.
-
Niemeyer CS, Frietze S, Coughlan C, Lewis SWR, Bustos Lopez S, Saviola AJ, Hansen KC, Medina EM, Hassell JE, Kogut S, Traina-Dorge V, Nagel MA, Bruce KD, Restrepo D, Mahalingam R, Bubak AN. Suppression of the host antiviral response by non-infectious varicella zoster virus extracellular vesicles. J Virol. 2024 Aug 20; 98(8):e0084824.
-
Niemeyer CS, Traina-Dorge V, Doyle-Meyers L, Das A, Looper J, Mescher T, Feia B, Medina E, Nagel MA, Mahalingam R, Bubak AN. Simian varicella virus infection and reactivation in rhesus macaques trigger cytokine and A?40/42 alterations in serum and cerebrospinal fluid. J Neurovirol. 2024 02; 30(1):86-99.
-
Levin MJ, Ginde AA, Schmid DS, Lang N, Canniff J, Schwartz RS, Weinberg A. Effect of high dose vitamin D supplementation on subsequent immune responses to administration of the live herpes zoster vaccine to long-term care residents. Vaccine. 2024 Apr 02; 42(9):2278-2281.
-
Zerbo O, Bartlett J, Fireman B, Lewis N, Goddard K, Dooling K, Duffy J, Glanz J, Naleway A, Donahue JG, Klein NP. Effectiveness of Recombinant Zoster Vaccine Against Herpes Zoster in a Real-World Setting. Ann Intern Med. 2024 02; 177(2):189-195.
-
Li E, Closmann JJ, Jordan RC. Herpes zoster: treatment, management, and prevention with the recombinant DNA vaccine. Gen Dent. 2024 Jan-Feb; 72(1):54-57.
-
Laing KJ, Ford ES, Johnson MJ, Levin MJ, Koelle DM, Weinberg A. Recruitment of naive CD4+ T cells by the recombinant zoster vaccine correlates with persistent immunity. J Clin Invest. 2023 12 01; 133(23).
-
Weinberg A, Scott Schmid D, Leung J, Johnson MJ, Miao C, Levin MJ. Predictors of 5-Year Persistence of Antibody Responses to Zoster Vaccines. J Infect Dis. 2023 11 11; 228(10):1367-1374.
-
Bubak AN, Coughlan C, Posey J, Saviola AJ, Niemeyer CS, Lewis SWR, Lopez SB, Solano A, Tyring SK, Delaney C, Neeves KB, Mahalingam R, Hansen KC, Nagel MA. Zoster-Associated Prothrombotic Plasma Exosomes and Increased Stroke Risk. J Infect Dis. 2023 04 18; 227(8):993-1001.
-
Nelson JC, Ulloa-P?rez E, Yu O, Cook AJ, Jackson ML, Belongia EA, Daley MF, Harpaz R, Kharbanda EO, Klein NP, Naleway AL, Tseng HF, Weintraub ES, Duffy J, Yih WK, Jackson LA. Active Postlicensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data. Am J Epidemiol. 2023 02 01; 192(2):205-216.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|